Get started
Author

Austin G. Yang

Observed name: Austin Yang
Observed institutions: Children's Hospital of Philadelphia, Wright State University, Hospital of the University of Pennsylvania, Abramson Cancer Center, University of Pennsylvania, University of California, Berkeley
ORCID: 0009-0007-1620-3493
Observed ORCID: 0009-0007-1620-3493
OpenAlex ID: A5032275215
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome
2025 · Changya Chen, Jason Xu, et al. · Blood · 17
Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment
2024 · Adam Barsouk, Omar Elghawy, et al. · Cancers · 7
PDF
Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome
2025 · Omar Elghawy, Jonathan H. Sussman, et al. · JAMA Dermatology · 6
Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma
2024 · Omar Elghawy, Adam Barsouk, et al. · Immunotherapy · 4
PDF
Survival Disparities by Sex, Race, and Age in the Era of Contemporary Advanced Urothelial Carcinoma Therapy: A Real-World Analysis
2025 · Adam A. Barsouk, Austin Yang, et al. · Clinical Genitourinary Cancer · 3
PDF
STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL
2025 · Jason Xu, Jonathan H. Sussman, et al. · Blood · 2
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
2026 · Jason Xu, Michael McCoy, et al. · Blood Advances · 1
PDF
Efficacy and safety of lisocabtagene maraleucel monotherapy in relapsed or refractory large B-cell lymphoma: A systematic review and meta-analysis of clinical trials and real-world studies
2025 · Jerry Qi, Daniel Park, et al. · Blood · 1
PDF
Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome
2024 · Omar Elghawy, Austin G. Yang, et al. · Journal of the American Academy of Dermatology · 1
Interferon-Activated Gene Signatures Associate with Chemotherapy Resistance and Sensitivity to JAK-Inhibition in Refractory ETP-ALL
2024 · Jason Xu, Jonathan Sussman, et al. · Blood · 1
S3808 Cat Cautious: Doxycycline as a Possible Culprit of Drug-Induced Liver Injury
2023 · Lakmal Ekanayake, Shaina Ailawadi, et al. · The American Journal of Gastroenterology · 1
EGFR, HER2 alterations in advanced urothelial carcinoma (aUC): A retrospective analysis on survival outcomes.
2026 · Pearl Subramanian, Adam Barsouk, et al. · Journal of Clinical Oncology
PDF
Risk of central nervous system metastasis and survival in HER2+ positive breast and non-breast cancers
2025 · Omar Elghawy, John S Wang, et al. · Neuro-Oncology Practice
Survival after osimertinib dose-reduction, discontinuation in 1L EGFR -mutated metastatic non-small cell lung cancer (mNSCLC).
2025 · Adam Barsouk, Omar Elghawy, et al. · Journal of Clinical Oncology
PDF
Survival with EGFR , HER2 alterations in aUC: A multi-institution, real-world cohort.
2025 · Adam Barsouk, Jonathan Henry Sussman, et al. · Journal of Clinical Oncology
Works count: 15
Citation count: 44
H-index: 4
I10-index: 1
Year
Topic
Type